Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on July 16, 2026

Jul. 16, 2026

Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

Indeterminate GlobeNewswire

Jul. 16, 2026

Resignation of Director

Indeterminate GlobeNewswire

Jul. 16, 2026

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

Indeterminate GlobeNewswire

Jul. 16, 2026

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Indeterminate GlobeNewswire

Jul. 16, 2026

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 16, 2026

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

Indeterminate GlobeNewswire

Jul. 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 16, 2026

Remix Therapeutics to Present at AACR Drug Discovery and Development Conference

Indeterminate GlobeNewswire

Jul. 16, 2026

Palomino Laboratories Announces Binding LOI to Acquire Vega Links Inc. to Create a Next-Generation AI Interconnect Company

Indeterminate GlobeNewswire

Jul. 16, 2026

Aurora Mobile's EngageLab Partners with Mocasa: Building a Robust Security Foundation for Digital Credit with Advanced OTP Solutions

Indeterminate GlobeNewswire

Jul. 16, 2026

Curative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology Platform

Indeterminate GlobeNewswire

Jul. 16, 2026

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025

Indeterminate GlobeNewswire

Jul. 16, 2026

Diagonal Therapeutics Announces First Patient Dosed in Phase 1/2 DIAMOND Clinical Trial of DIAG723 for Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Jul. 16, 2026

Ragnarok: The New World Officially Launched in Southeast Asia on July 16, 2026

Indeterminate GlobeNewswire

Jul. 16, 2026

Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 16, 2026

4TEEN4 Receives U.S. FDA Fast Track Designation for Invobenitug in Cardiogenic Shock

Indeterminate GlobeNewswire

Jul. 16, 2026

Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US

Indeterminate GlobeNewswire

Jul. 16, 2026

GenOptima Launches Results-as-a-Service GEO Infrastructure to Help Enterprises Ensure Outcome in AI Search

Indeterminate GlobeNewswire

Jul. 16, 2026

Traini Partners with Transsion to Bring Native Pet Emotion Translation to Smartphones

Indeterminate GlobeNewswire

Jul. 16, 2026

Denodo Platform 9.5 stellt agentenbasierter KI aktiven Kontext bereit, um effektiv und verantwortungsbewusst zu agieren

Indeterminate GlobeNewswire